R1	Has_qualifier Arg1:T3 Arg2:T2	
R2	Has_temporal Arg1:T3 Arg2:T1	
R3	Has_temporal Arg1:T5 Arg2:T4	
R4	Subsumes Arg1:T7 Arg2:T8	
R5	Has_multiplier Arg1:T9 Arg2:T7	
R6	Has_negation Arg1:T9 Arg2:T10	
R7	Subsumes Arg1:T20 Arg2:T21	
*	OR T6 T15 T16 T17 T18 T19 T20 T22 T13 T12 T14
R8	AND Arg1:T6 Arg2:T9	
R9	AND Arg1:T5 Arg2:T6	
R10	Subsumes Arg1:T27 Arg2:T28	
*	OR T27 T29
R11	AND Arg1:T26 Arg2:T27	
*	OR T24 T26 T25
*	OR T33 T34 T31 T32
R12	Has_temporal Arg1:T33 Arg2:T37	
R13	Has_qualifier Arg1:T33 Arg2:T35	
*	OR T39 T38
R14	Has_qualifier Arg1:T39 Arg2:T40	
R15	Has_qualifier Arg1:T39 Arg2:T42	
*	OR T47 T46
R16	Has_qualifier Arg1:T45 Arg2:T47	
T1	Temporal 0 5	Prior
T2	Qualifier 17 32	investigational
T3	Drug 33 49	anti-HIV vaccine
T4	Temporal 51 58	Ongoing
T5	Procedure 59 66	therapy
T6	Drug 94 118	Systemic corticosteroids
T7	Multiplier 120 132	Short course
T8	Multiplier 133 162	less than or equal to 21 days
T9	Condition 166 181	corticosteroids
T10	Negation 182 192	is allowed
T12	Drug 194 226	Systemic chemotherapeutic agents
T13	Drug 228 255	Nephrotoxic systemic agents
T14	Drug 267 282	aminoglycosides
T15	Drug 284 298	amphotericin B
T16	Drug 300 309	cidofovir
T17	Drug 311 320	cisplatin
T18	Drug 322 331	foscarnet
T19	Drug 333 344	pentamidine
T20	Procedure 346 373	Immunomodulatory treatments
T21	Drug 384 397	Interleukin-2
T22	Drug 399 421	Investigational agents
T24	Condition 429 436	allergy
T25	Condition 437 448	sensitivity
T26	Condition 456 472	hypersensitivity
T27	Drug 476 501	components of study drugs
T28	Drug 503 506	ART
T29	Drug 508 529	or their formulations
T31	Condition 546 557	alcohol use
T32	Condition 554 557	use
T33	Condition 538 542;561 571	drug dependence
T34	Condition 546 553;561 571	alcohol dependence
T35	Qualifier 577 629	would interfere with adherence to study requirements
T37	Temporal 531 537	Active
T38	Condition 650 669	psychiatric illness
T39	Condition 639 646;662 669	medical illness
T40	Qualifier 631 638	Serious
T42	Qualifier 675 739	would interfere with the ability to adhere to study requirements
T43	Condition 741 748;758 779	Chronic hepatitis B infection
T44	Condition 752 779	acute hepatitis B infection
T45	Drug 788 812	female hormonal products
T46	Qualifier 822 830;834 845	estrogen derivatives
T47	Qualifier 822 830	estrogen
